Erratum to: Dermatol Ther (Heidelb) (2017) 7:81–96 DOI 10.1007/s13555-016-0161-2
The authors would like to publish an erratum to correct the mistakes in Fig. 4 legend and in the text under the heading “Study Assessments and Endpoints” in the published article. The correct texts are given below.
-
Under the Fig. 4 legend the text currently reads: “a Partial clearance defined as ≤75% reduction in the number of clinically visible AK lesions. 5-FU/SA 5-fluorouracil 0.5%/salicylic acid 10%, AK actinic keratosis”.
The figure “≤75%” should be “≥75%”.
The first paragraph of “Study Assessments and Endpoints” has repeated text. The text “and proportional change from baseline in the total number of lesions at each treatment visit and 8 weeks after the end of treatment.” should be removed.
Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Footnotes
The online version of the original article can be found under doi:10.1007/s13555-016-0161-2.